Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$933,370
+$635,828 QoQ
Shares Held
51,256
+144.8% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 183 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CGEM ranks #138 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CGEM

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $933,370 51,256
2026-03-31 $297,542 20,939
2025-12-31 $626,319 60,514
2025-09-30 $231,963 39,117
2025-06-30 $246,524 32,739
2025-03-31 $194,450 25,687
2024-12-31 $302,843 24,864
2024-09-30 $281,365 16,808
2024-06-30 $242,276 13,892
2024-03-31 $156,768 9,200
2023-12-31 $81,795 8,027
2023-09-30 $53,928 5,959
2023-06-30 $97,679 9,078
2023-03-31 $47,549 4,648
2022-09-30 $910 71
2022-06-30 $4,422 345
2022-03-31 $116,080 11,087
2021-12-31 $301,023 19,509
2021-09-30 $1,263 56
2021-06-30 $204,017 7,923
2021-03-31 $170,638 4,095